angioplasty
NEW ORLEANS, June 7 -- There is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone, according to a landmark study focused exclusively on patients with both conditions.
LAS VEGAS, NV (May 8, 2009) -- A study from one of the largest public health systems in the country has found that African American patients experienced significantly worse outcomes after angioplasty and stenting than patients of other races, though researchers are not sure why.
Exercise is one of eight preventive measures identified by the European Heart Health Charter and features prominently in the scientific programme of EuroPRevent 2009, the congress of the European Association of Cardiovascular Prevention and Rehabilitation.1 EuroPRevent 2009 takes place in Stockholm, Sweden, on 6-9 May.
NEW YORK, NY - MAY 6, 2009 - The Cardiovascular Research Foundation (CRF) announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published today in The New England Journal of Medicine.
LAS VEGAS, NV (May 6, 2009) -- Age, condition and treatment delay are among the reasons women who undergo angioplasty for heart attack often do not fare as well as do men, according to two studies presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.
Healthcare Reform should start with "evidence-based reimbursement", structuring physician payment incentives around existing empirical evidence of clinical benefit, which would improve quality and reduce the cost of healthcare, says a commentary written by two cardiologists and published in Circulation: Cardiovascular Quality and Outcomes.
The 9th Annual Spring Meeting of the European Society of Cardiology Council on Cardiovascular Nursing and Allied Professions (CCNAP), organised in cooperation with the Irish Nurses Cardiovascular Association (INCA), is being held at the Royal Dublin Society, Dublin, Ireland, on 24-25 April.
Jerusalem, March 9, 2009 - An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Medicare patients treated at top-rated hospitals nationwide across the most common Medicare diagnoses and procedures are 27 percent less likely to die, on average, than those admitted to all other hospitals.
In a heart attack, the saying goes, ''Time is muscle.'' The faster a person gets treated, the better his or her chances of survival and recovery. But a new study finds that women who have heart attacks wait longer than men to receive an emergency procedure that can re-open clogged blood vessels and restore blood flow to the heart muscle. The study also finds that the longer any patient waits for this treatment, the higher his or her chances are of dying before leaving the hospital.
Combining stented angioplasty and robotically assisted ''keyhole'' bypass surgery is safe and may help patients with extensive cardiovascular disease, researchers report. Doctors performed the hybrid approach on 12 patients, all of whom remain free of chest pain. ''This technique puts together the best of both worlds... However, it is important to emphasize that this is a small pilot study, and that robotically enhanced minimally invasive direct coronary artery bypass is a recent technique that is used in only a few centers worldwide.''
While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers have found that stents have no impact on mortality over the long term. In the largest such analysis of its kind, the researchers said their findings have important economic and clinical implications for physicians who are deciding whether their heart patients should receive coronary artery bypass surgery, or less-invasive angioplasty, which includes the placement of a stent.
With the help of snake venom and sophisticated laboratory testing, scientists believe they've uncovered the reason why a group of new heart medications were doing some patients more harm than good. Researchers from Wake Forest University Baptist Medical Center and colleagues report the findings in the current on-line issue of The Journal of Molecular Biology. ''Our findings suggest that drug developers should take a different approach,'' said Roy Hantgan, Ph.D., principal investigator, ''and we've also developed a way to test drugs for these harmful effects before they are given to patients.''
A substantial proportion of heart attack patients may be resistant to the blood thinner clopidogrel -- and face an increased risk of recurrent blockages, researchers report. Researchers studied clopidogrel, a commonly used drug that helped prevent blood clotting in 60 patients, average age 58, who were treated with angioplasty and stenting after heart attacks.
In an unusual paradox, smoking cigarettes-a deadly habit that contributes to the development of peripheral artery disease-actually helps arteries stay open following a procedure to repair clogged blood vessels in the legs, according to a study in the June issue of Radiology. The study found that habitual to heavy smokers who continued to smoke after angioplasty had a lower rate of restenosis, or re-narrowing of the arteries, than nonsmokers.
